Siga Technologies (SIGA) Net Cash Flow (QoQ) (2010 - 2025)
Powered by 
Analysis
Siga Technologies (SIGA) Net Cash Flow (QoQ) (2010 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn |
| 10 | Siga Technologies | 235.60 Mn | 80.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -152.04% |
| Jun 30, 2025 | 193.88% |
| Mar 31, 2025 | -87.76% |
| Dec 31, 2024 | 830.86% |
| Sep 30, 2024 | 79.20% |
| Jun 30, 2024 | -488.14% |
| Mar 31, 2024 | -107.94% |
| Dec 31, 2023 | 1,649.83% |
| Sep 30, 2023 | 87.08% |
| Jun 30, 2023 | -333.67% |
| Mar 31, 2023 | 254.12% |
| Dec 31, 2022 | -129.20% |
| Sep 30, 2022 | 87.65% |
| Jun 30, 2022 | -177.27% |
| Mar 31, 2022 | 385.70% |
| Dec 31, 2021 | 282.11% |
| Sep 30, 2021 | 29.53% |
| Jun 30, 2021 | 29.23% |
| Mar 31, 2021 | -128.97% |
| Dec 31, 2020 | 53.24% |